⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for refractory mixed phenotype acute leukemia

Every month we try and update this database with for refractory mixed phenotype acute leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of SNDX-5613 in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory LeukemiaNCT05761171
Recurrent Acute...
Recurrent Acute...
Recurrent Acute...
Recurrent Acute...
Recurrent Acute...
Recurrent Mixed...
Refractory Acut...
Refractory Acut...
Refractory Acut...
Refractory Acut...
Refractory Acut...
Refractory Mixe...
Biospecimen Col...
Bone Marrow Asp...
Calaspargase Pe...
Cytarabine
Echocardiograph...
Fludarabine Pho...
Hydrocortisone ...
Lumbar Puncture
Methotrexate
Multigated Acqu...
Prednisolone
Prednisone
Revumenib
Vincristine Sul...
1 Month - 6 YearsChildren's Oncology Group
211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic SyndromeNCT03670966
Acute Lymphobla...
Acute Myeloid L...
Acute Myeloid L...
Chronic Myelomo...
Myelodysplastic...
Recurrent Acute...
Recurrent Acute...
Refractory Acut...
Refractory Acut...
Recurrent Mixed...
Refractory Mixe...
Hematopoietic a...
Astatine At 211...
Cyclophosphamid...
Total-Body Irra...
Peripheral Bloo...
Bone Marrow Tra...
Mycophenolate M...
Recombinant Gra...
Fludarabine Pho...
Tacrolimus
Bone Marrow Asp...
Biospecimen Col...
18 Years - 75 YearsFred Hutchinson Cancer Center
A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to TreatNCT05320380
Recurrent Acute...
Recurrent B Acu...
Recurrent Mixed...
Recurrent T Acu...
Refractory Acut...
Refractory B Ac...
Refractory Mixe...
Refractory T Ac...
Anti-CD123 ADC ...
Bone Marrow Asp...
Cytarabine
Fludarabine Pho...
Hydrocortisone ...
Liposome-encaps...
Methotrexate
Prednisolone
12 Months - 22 YearsChildren's Oncology Group
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic LeukemiaNCT04375631
Recurrent Acute...
Recurrent Chron...
Recurrent Myelo...
Refractory Acut...
Refractory Chro...
Refractory Mixe...
Refractory Myel...
Refractory Acut...
Refractory Acut...
Cladribine
Cyclophosphamid...
Cyclosporine
Cytarabine
Filgrastim
Hematopoietic C...
Mitoxantrone
Mycophenolate M...
Mycophenolate S...
Total-Body Irra...
Idarubicin
Fludarabine
Cytarabine
Multigated Acqu...
Echocardiograph...
X-Ray Imaging
Bone Marrow Bio...
Bone Marrow Asp...
18 Years - Fred Hutchinson Cancer Center
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute LeukemiaNCT03128034
Acute Lymphobla...
Acute Myeloid L...
Acute Myeloid L...
Chronic Myelomo...
Myelodysplastic...
Recurrent Acute...
Refractory Acut...
Recurrent Acute...
Recurrent Mixed...
Refractory Acut...
Refractory Mixe...
Mixed Phenotype...
Cyclosporine
Fludarabine Pho...
Laboratory Biom...
Mycophenolate M...
Peripheral Bloo...
Pharmacological...
Pretargeted Rad...
Total-Body Irra...
18 Years - 75 YearsFred Hutchinson Cancer Center
A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to TreatNCT05320380
Recurrent Acute...
Recurrent B Acu...
Recurrent Mixed...
Recurrent T Acu...
Refractory Acut...
Refractory B Ac...
Refractory Mixe...
Refractory T Ac...
Anti-CD123 ADC ...
Bone Marrow Asp...
Cytarabine
Fludarabine Pho...
Hydrocortisone ...
Liposome-encaps...
Methotrexate
Prednisolone
12 Months - 22 YearsChildren's Oncology Group
A Study of SNDX-5613 in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory LeukemiaNCT05761171
Recurrent Acute...
Recurrent Acute...
Recurrent Acute...
Recurrent Acute...
Recurrent Acute...
Recurrent Mixed...
Refractory Acut...
Refractory Acut...
Refractory Acut...
Refractory Acut...
Refractory Acut...
Refractory Mixe...
Biospecimen Col...
Bone Marrow Asp...
Calaspargase Pe...
Cytarabine
Echocardiograph...
Fludarabine Pho...
Hydrocortisone ...
Lumbar Puncture
Methotrexate
Multigated Acqu...
Prednisolone
Prednisone
Revumenib
Vincristine Sul...
1 Month - 6 YearsChildren's Oncology Group
Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic SyndromeNCT03404193
Acute Myeloid L...
Acute Myeloid L...
Blastic Plasmac...
Chronic Myelomo...
Mixed Phenotype...
Myelodysplastic...
Recurrent Acute...
Recurrent Acute...
Recurrent Blast...
Recurrent Chron...
Recurrent Mixed...
Refractory Acut...
Refractory Blas...
Refractory Chro...
Refractory Mixe...
Decitabine
Laboratory Biom...
Venetoclax
18 Years - M.D. Anderson Cancer Center
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid NeoplasmsNCT04797767
Acute Biphenoty...
Acute Myeloid L...
Mixed Phenotype...
Myeloid Neoplas...
Relapsed Acute ...
Relapsed Acute ...
Relapsed Mixed ...
Relapsed Myeloi...
Refractory Acut...
Refractory Acut...
Refractory Mixe...
Refractory Myel...
Recurrent Myelo...
Cladribine
Cytarabine
Mitoxantrone
Recombinant Gra...
Venetoclax
18 Years - University of Washington
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: